What CCL Pharmaceuticals does

CCL Pharmaceuticals is a Pakistan-headquartered life sciences company operating as a core portfolio company of CCL Holding Pvt. Ltd., a diversified private investment platform. Founded in 1965 and headquartered in Lahore, the company manufactures and distributes prescription and over-the-counter pharmaceuticals spanning cardiometabolic, acute, and specialty care therapeutic areas, alongside consumer health products. Manufacturing is anchored by three facilities — two PIC/S-certified plants in Pakistan and one in Vietnam — supporting exports to 30+ countries across Asia, Africa, the Middle East, Europe, and the Americas. Distribution is conducted through wholesale/retail pharmacy channels and direct supply to hospitals and healthcare institutions.

CCL Holding extends the franchise into adjacent verticals through portfolio companies: Healthwire (an integrated digital health platform offering online consultations, diagnostic lab services, and e-pharmacy delivery in Pakistan); Cozmetica and OneSkin (digital-first e-commerce platforms for curated beauty and science-led skincare serving Pakistani consumers); Mitchell's Fruit Farms (a heritage food company founded in 1933, acquired at 58.78% in October 2025, producing 80+ products across 12 categories); and Biomasdar (Pakistan's first natural ingredients extraction company supplying oleoresins, herbal extracts, essential oils, spray-dried powders, and natural flavors/colors to food, wellness, and pharmaceutical industries globally). The Dilawar Hussain Foundation, the group's philanthropic arm, became a member of the International Diabetes Federation in 2025.

The business model combines one-time-sale revenue from pharmaceutical and consumer health product distribution (manufacturing-led B2B through pharmacy and hospital channels) with transaction-based DTC e-commerce revenue from Cozmetica, OneSkin, and Healthwire's e-pharmacy, and B2B ingredients distribution via Biomasdar. Pricing is not publicly disclosed. Geographic reach is anchored in Pakistan and Vietnam for manufacturing, with international revenue derived from export distribution in 30+ countries (one corporate source citing 40+). The holding company states a long-term, capital-disciplined ownership model across Healthcare & Life Sciences, Food & Beverage, and Beauty & Personal Care, and has positioned itself publicly around sustainability (CERB Sustainability Summit 2025 SDG Leader) and diabetes-focused social impact.

Name

CCL Pharmaceuticals

Legal name

CCL Holding Pvt. Ltd.

Website

https://cclholding.com

Company type

Private

Founded year

1965

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

CCL Pharmaceuticals, founded in 1965 and headquartered in Lahore, manufactures cardiometabolic, acute, and specialty care pharmaceuticals plus consumer health products across three facilities (two PIC/S-certified) in Pakistan and Vietnam, distributing to 30+ countries. It operates within CCL Holding's broader healthcare, food, beauty, and digital health portfolio.

Ownership category

akta.pro rank

Product category

Pharmaceuticals Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Cardiology & Vascular Specialty Pharmaceuticals (HLAIACAG)

Keywords

• Pharmaceutical manufacturing
• Cardiometabolic medicines
• Consumer health products
• Specialty care pharmaceuticals
• PIC/S certified manufacturing

Headquarters

HQ city

Lahore

HQ country

Pakistan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceuticals: Manufacture and sale of prescription and OTC pharmaceuticals spanning cardiometabolic, acute, and specialty care therapeutic areas through established pharmaceutical distribution channels.
2. Consumer Health: Sale of consumer health products including over-the-counter medicines and health-related consumer goods.
3. Digital-first beauty and personal care e-commerce: Cozmetica and OneSkin operate direct-to-consumer e-commerce platforms in Pakistan offering curated international and local beauty and personal care brands.

Go-to-market motion2 records

Distribution channels7 records

Marketing channels3 records

Core offering

CCL Pharmaceuticals manufactures and sells prescription and over-the-counter pharmaceutical products across cardiometabolic, acute, and specialty care therapeutic areas, with production from two PIC/S-certified plants in Pakistan and a facility in Vietnam. The company also offers consumer health products through its parent platform CCL Holding's portfolio of digital health, beauty and personal care, food and beverage, and natural ingredients businesses.

Product overview

CCL Pharmaceuticals is part of CCL Holding's investment portfolio. It is a diversified life sciences company with over six decades of expertise, operating across Pharmaceuticals (cardiometabolic, acute, and specialty care) and Consumer Health divisions, alongside portfolio companies Healthwire (digital health platform), Cozmetica (digital-first beauty platform), OneSkin (skincare brand), Mitchell's Fruit Farms (heritage food company), and Biomasdar (natural ingredients extraction). The company maintains manufacturing facilities in Pakistan and Vietnam.

Differentiator

Problem solved

Functional benefit

Products and services

• CCL Pharmaceuticals (Cardiometabolic, Acute, and Specialty Care) Manufacture and distribution of prescription and over-the-counter pharmaceutical products spanning cardiometabolic, acute, and specialty care therapeutic areas for healthcare providers, hospitals, and pharmacies.
• CCL Pharmaceuticals Consumer Health Science-backed consumer health products offered alongside the pharmaceutical portfolio, delivered through retail and digital channels.
• Healthwire Integrated digital health platform offering online doctor consultations, diagnostic lab services, and e-pharmacy with medicine delivery for consumers in Pakistan.
• Cozmetica Digital-first beauty and personal care e-commerce platform serving Pakistani consumers with a curated mix of international and local brands.
• OneSkin Digital-first skincare brand offering clean, science-led formulations tailored for modern skin needs in Pakistan.
• Mitchell's Fruit Farms Heritage food company producing over 80 products across 12 categories including beverages, jams and spreads, confectionery, and processed foods, distributed through retail channels in Pakistan.
• Biomasdar Pakistan's first natural ingredients extraction company delivering clean-label, plant-based solutions for food, wellness, and pharmaceutical industries, with capabilities spanning oleoresins, herbal extracts, essential oils, spray-dried powders, and natural flavors and colors.

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Three partnerships are on record, tiered core and minor.

• Mitchell's Fruit Farms Ltd.coreStrategic or Co-development Partner · 16 October 2025CCL Holding acquired 13,447,058 ordinary shares, representing 58.78% of the total issued ordinary share capital of Mitchell's Fruit Farms Ltd. on October 16, 2025. Mitchell's is a heritage food company founded in 1933, producing over 80 products across 12 categories including beverages, jams, confectionery, and processed foods. The acquisition expands CCL Holding's Food & Beverage portfolio.
• International Diabetes Federation (IDF)coreStrategic or Co-development Partner · 1 January 2025Dilawar Hussain Foundation (DHF), the philanthropic arm of CCL Holding, became an official member of the International Diabetes Federation in 2025. IDF is a global umbrella organisation with over 250 national diabetes associations in 160+ countries. The membership supports DHF's diabetes care, prevention, and awareness programs in Pakistan and aligns with global standards.
• Centre of Excellence in Responsible Business (CERB) / Pakistan Business CouncilminorGTM or Marketing Partner · 1 January 2025CCL Pharmaceuticals participated as an SDG Leader at the CERB Sustainability Summit 2025. CERB is an initiative of the Pakistan Business Council that brings together business leaders to accelerate responsible business conduct, promoting climate action, environmental stewardship, and UN Sustainable Development Goals.

Scale indicators7 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Highnoon Laboratories: Highnoon Laboratories is a publicly listed Pakistani pharma company manufacturing branded generics and consumer health products for domestic and export markets — comparable to CCL's manufacturing scale, therapeutic breadth, and export-driven business model.
• Sami Pharmaceuticals: Sami Pharmaceuticals is a Pakistani specialty pharma manufacturer serving domestic and export markets with branded prescription products — comparable to CCL in product positioning and Pakistan-domestic manufacturing footprint.
• PharmEvo: PharmEvo is a leading Pakistani pharmaceutical company focused on cardiometabolic, neurology, and critical-care therapeutics with international presence — directly comparable to CCL's specialty therapeutic concentration and emerging-market export footprint.
• Hilton Pharma: Hilton Pharma is a top-tier Pakistani pharmaceutical manufacturer with branded generics across therapeutic areas including cardiology, served through a national sales force — directly comparable to CCL in product breadth, therapeutic focus, and domestic Pakistani market presence.
• Getz Pharma: Getz Pharma is one of Pakistan's largest privately held pharmaceutical manufacturers with a multi-therapeutic portfolio spanning cardio, diabetes, CNS, and consumer health, exporting to multiple emerging markets — highly comparable to CCL in scale, geography, regulatory positioning, and cardiometabolic emphasis.
• AGP Limited: AGP Limited is one of Pakistan's largest pharmaceutical manufacturers with a diversified branded-generics portfolio and significant export operations — comparable to CCL in scale, business model, and therapeutic coverage.

Broad incumbents

• Abbott Laboratories: Abbott is a diversified global healthcare major with established branded generics and consumer health presence in emerging Asia — overlapping with CCL's prescription and consumer health portfolios as a multinational incumbent.
• Sanofi: Sanofi is a global pharmaceutical major with a strong cardiometabolic and specialty-care franchise serving emerging markets — broader but directly competitive with CCL in the cardiometabolic space where Sanofi fields branded originator products.
• Bayer Pharmaceuticals: Bayer is a global pharmaceutical incumbent with a deep cardiology and women's health specialty franchise serving emerging markets — competes with CCL's cardiometabolic focus from a multinational origin-brand position.
• GSK Pakistan: GSK Pakistan is the local subsidiary of a global pharmaceutical incumbent with deep therapy-area breadth and prescriber relationships across Pakistan — overlapping with CCL on therapeutic categories but competing as a multinational with global R&D backing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ccl-pharmaceuticals
• Xx.com/cclholdings
• Facebookfacebook.com/weareCCL

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CCL Pharmaceuticals